These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 15491423)

  • 41. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions.
    Tapia B; Padial A; Sánchez-Sabaté E; Alvarez-Ferreira J; Morel E; Blanca M; Bellón T
    J Allergy Clin Immunol; 2004 Aug; 114(2):335-40. PubMed ID: 15316512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of long term dermal sensitization followed by intratracheal challenge method to identify low-dose chemical-induced respiratory allergic responses in mice.
    Fukuyama T; Ueda H; Hayashi K; Tajima Y; Shuto Y; Saito TR; Harada T; Kosaka T
    Toxicol Lett; 2008 Oct; 181(3):163-70. PubMed ID: 18708131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A role for TARC/CCL17, a CC chemokine, in systemic lupus erythematosus.
    Okamoto H; Koizumi K; Yamanaka H; Saito T; Kamatani N
    J Rheumatol; 2003 Nov; 30(11):2369-73. PubMed ID: 14677179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin.
    Reiss Y; Proudfoot AE; Power CA; Campbell JJ; Butcher EC
    J Exp Med; 2001 Nov; 194(10):1541-7. PubMed ID: 11714760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-17 is a negative regulator of established allergic asthma.
    Schnyder-Candrian S; Togbe D; Couillin I; Mercier I; Brombacher F; Quesniaux V; Fossiez F; Ryffel B; Schnyder B
    J Exp Med; 2006 Nov; 203(12):2715-25. PubMed ID: 17101734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppressive activity of epinastine hydrochloride on TARC production from human peripheral blood CD4+ T cells in-vitro.
    Kanai K; Asano K; Hisamitsu T; Suzaki H
    J Pharm Pharmacol; 2005 Aug; 57(8):1027-36. PubMed ID: 16102259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine.
    Kang SG; Piniecki RJ; Hogenesch H; Lim HW; Wiebke E; Braun SE; Matsumoto S; Kim CH
    Gastroenterology; 2007 Mar; 132(3):966-81. PubMed ID: 17324406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB.
    Vestergaard C; Johansen C; Otkjaer K; Deleuran M; Iversen L
    Cytokine; 2005 Jan; 29(2):49-55. PubMed ID: 15598438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CCL17 and CCL22 attenuate CCL5-induced mast cell migration.
    Juremalm M; Olsson N; Nilsson G
    Clin Exp Allergy; 2005 Jun; 35(6):708-12. PubMed ID: 15969658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity.
    Goebeler M; Trautmann A; Voss A; Bröcker EV; Toksoy A; Gillitzer R
    Am J Pathol; 2001 Feb; 158(2):431-40. PubMed ID: 11159181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nickel-specific CD4(+) and CD8(+) T cells display distinct migratory responses to chemokines produced during allergic contact dermatitis.
    Sebastiani S; Albanesi C; Nasorri F; Girolomoni G; Cavani A
    J Invest Dermatol; 2002 Jun; 118(6):1052-8. PubMed ID: 12060402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis.
    Hayakawa I; Hasegawa M; Matsushita T; Yanaba K; Kodera M; Komura K; Takehara K; Sato S
    Rheumatology (Oxford); 2005 Jul; 44(7):873-8. PubMed ID: 15797972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first beta-strand of chemokine.
    Sebastiani S; Danelon G; Gerber B; Uguccioni M
    Eur J Immunol; 2005 Mar; 35(3):746-56. PubMed ID: 15714581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The -431C>T polymorphism of thymus and activation-regulated chemokine increases the promoter activity but is not associated with susceptibility to atopic dermatitis in Japanese patients.
    Tsunemi Y; Komine M; Sekiya T; Saeki H; Nakamura K; Hirai K; Kakinuma T; Kagami S; Fujita H; Asano N; Tanida Y; Wakugawa M; Torii H; Tamaki K
    Exp Dermatol; 2004 Nov; 13(11):715-9. PubMed ID: 15500644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
    Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
    Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment.
    Oshio T; Sasaki Y; Funakoshi-Tago M; Aizu-Yokota E; Sonoda Y; Matsuoka H; Kasahara T
    Int Immunopharmacol; 2009 Apr; 9(4):403-11. PubMed ID: 19162238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.
    Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Asano N; Mitsui H; Tada Y; Wakugawa M; Watanabe T; Torii H; Komine M; Asahina A; Nakamura K; Tamaki K
    J Allergy Clin Immunol; 2003 Mar; 111(3):592-7. PubMed ID: 12642842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
    Furukawa H; Takahashi M; Nakamura K; Kaneko F
    J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
    Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
    Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of cilomilast on dendritic cell function in contact sensitivity and dendritic cell migration through skin.
    Bäumer W; Tschernig T; Sülzle B; Seegers U; Lührmann A; Kietzmann M
    Eur J Pharmacol; 2003 Nov; 481(2-3):271-9. PubMed ID: 14642795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.